1-3 of 3
melanoma
Close
Sort by
Journal Articles

Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Catherine S. Diefenbach, Brandilyn A. Peters, Huilin Li, Bruce Raphael, Tibor Moskovits, Kenneth Hymes, Jonas Schluter, J. Chen, N. Nora Bennani, Thomas E. Witzig, Jiyoung Ahn
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1194–1198.
https://doi.org/10.1182/bloodadvances.2020003129
Published: 2021
Includes: Supplemental data
Journal Articles

The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium

Thejaswi Kalagara, Tracy Moutsis, Yi Yang, Karin I. Pappelbaum, Anne Farken, Lucia Cladder-Micus, Sabine Vidal-y-Sy, Axel John, Alexander T. Bauer, Bruno M. Moerschbacher, Stefan W. Schneider, Christian Gorzelanny
Journal: Blood Advances
Blood Adv (2018) 2 (18): 2347–2357.
https://doi.org/10.1182/bloodadvances.2017013995
Published: 2018
Includes: Multimedia, Supplemental data
Journal Articles

Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia

Clinical Trials & Observations
Anne Sophie Kubasch, Rebekka Wehner, Serena Bazzurri, Antje Tunger, Sebastian Stasik, Marlene Garzarolli, Jörn Meinel, Gustavo Baretton, Friedegund Meier, Christian Thiede, Marc Schmitz, Uwe Platzbecker
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1187–1190.
https://doi.org/10.1182/bloodadvances.2017014811
Published: 2018
Includes: Supplemental data